CBX2 and hepatocellular carcinoma: A previous study reported that the increased mRNA expression of HP1-β/γ (CBX1/3) and CBX2/6/8 was correlated with a worse OS, while the overexpression of CBX7 was related to a greater OS in patients with hepatocellular carcinoma (17).